TY  - JOUR

T1  - The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.

JO  - BMC Cancer

UR  - http://dx.doi.org/10.1186/s12885-015-1066-7

PY  - 2015/02/14

AU  - Wilson C

AU  - Ottewell P

AU  - Coleman RE

AU  - Holen I

ED  - 

DO  - DOI: 10.1186/s12885-015-1066-7

PB  - BioMed Central

VL  - 15

Y2  - 2025/11/04

ER  -